Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted an application to the UK’s Medicine ...

Add Yahoo as a preferred source to see more of our stories on Google. Erectile dysfunction can cause a “self-perpetuating cycle of anxiety and performance pressure,” says one expert. (Photo ...

The MarketWatch News Department was not involved in the creation of this content. The new TRT program and brand identity marks the next chapter for the company that has treated more than 400,000 ...

ED is characterized by the inability to achieve or maintain an erection sufficient for sexual activity. It can be caused by various factors, including physical conditions such as cardiovascular ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

According to the National Institutes of Health (NIH), erectile dysfunction (ED) affects about 30 million men in the United States. While it’s not unusual to have difficulty maintaining an erection ...

Erectile dysfunction can indicate heart disease years before cardiovascular issues arise. In fact, most heart problems don’t ...

KNOXVILLE, Tenn. — Vincent Martin is like millions of men across the globe who struggle with erectile dysfunction. It's a topic many won't speak up about. However, Martin is ready to be heard. He ...

Shock-wave therapy looks like an effective method for treating erectile dysfunction (ED), but injections of platelet-rich plasma (PRP) proved no better than placebo, according to results from two ...

In some people with kidney stones, low-intensity shockwave therapy (LIST) breaks them up. And in some with heart disease and fractures, LIST coaxes the body to produce new blood vessels that help with ...

Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted ...